» Articles » PMID: 29215004

NLRP11 Attenuates Toll-like Receptor Signalling by Targeting TRAF6 for Degradation Via the Ubiquitin Ligase RNF19A

Overview
Journal Nat Commun
Specialty Biology
Date 2017 Dec 8
PMID 29215004
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The adaptor protein TRAF6 has a central function in Toll-like receptor (TLR) signalling, yet the molecular mechanisms controlling its activity and stability are unclear. Here we show that NLRP11, a primate specific gene, inhibits TLR signalling by targeting TRAF6 for degradation. NLRP11 recruits the ubiquitin ligase RNF19A to catalyze K48-linked ubiquitination of TRAF6 at multiple sites, thereby leading to the degradation of TRAF6. Furthermore, deficiency in either NLRP11 or RNF19A abrogates K48-linked ubiquitination and degradation of TRAF6, which promotes activation of NF-κB and MAPK signalling and increases the production of proinflammatory cytokines. Therefore, our findings identify NLRP11 as a conserved negative regulator of TLR signalling in primate cells and reveal a mechanism by which the NLRP11-RNF19A axis targets TRAF6 for degradation.

Citing Articles

Combination adjuvant improves influenza virus immunity by downregulation of immune homeostasis genes in lymphocytes.

Dollinger E, Hernandez-Davies J, Felgner J, Jain A, Hwang M, Strahsburger E Immunohorizons. 2025; 9(2).

PMID: 39849993 PMC: 11841980. DOI: 10.1093/immhor/vlae007.


REGγ is essential to maintain bone homeostasis by degrading TRAF6, preventing osteoporosis.

Du Y, Chen H, Zhou L, Guo Q, Gong S, Feng S Proc Natl Acad Sci U S A. 2024; 121(47):e2405265121.

PMID: 39536082 PMC: 11588133. DOI: 10.1073/pnas.2405265121.


RNF19A inhibits bladder cancer progression by regulating ILK ubiquitination and inactivating the AKT/mTOR signalling pathway.

Deng H, Ji G, Ma J, Cai J, Cheng S, Cheng F Biol Direct. 2024; 19(1):102.

PMID: 39508245 PMC: 11539788. DOI: 10.1186/s13062-024-00562-2.


Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis.

Pandey A, Li Z, Gautam M, Ghosh A, Man S Immunol Rev. 2024; 329(1):e13406.

PMID: 39351983 PMC: 11742652. DOI: 10.1111/imr.13406.


From periphery to center stage: 50 years of advancements in innate immunity.

Carpenter S, ONeill L Cell. 2024; 187(9):2030-2051.

PMID: 38670064 PMC: 11060700. DOI: 10.1016/j.cell.2024.03.036.


References
1.
Boone D, Turer E, Lee E, Ahmad R, Wheeler M, Tsui C . The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 2004; 5(10):1052-60. DOI: 10.1038/ni1110. View

2.
Suzuki N, Saito T . IRAK-4--a shared NF-kappaB activator in innate and acquired immunity. Trends Immunol. 2006; 27(12):566-72. DOI: 10.1016/j.it.2006.10.003. View

3.
Guo Z, Yu B, Ning B, Chan S, Lin Q, Li J . Genetically modified "obligate" anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma. J Hematol Oncol. 2015; 8:99. PMC: 4545364. DOI: 10.1186/s13045-015-0196-3. View

4.
Wu J, Chen Z . Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol. 2014; 32:461-88. DOI: 10.1146/annurev-immunol-032713-120156. View

5.
Kawai T, Akira S . The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010; 11(5):373-84. DOI: 10.1038/ni.1863. View